Fortress Biotech, Inc.FBIONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year gross profit growth rate
Latest
3.50%
↓ 87% below average
Average (39q)
26.54%
Historical baseline
Range
High:1252.00%
Low:-1289.44%
CAGR
-14.0%
Structural decline
| Period | Value |
|---|---|
| Q3 2025 | 3.50% |
| Q2 2025 | 37.43% |
| Q1 2025 | -10.37% |
| Q4 2024 | -0.31% |
| Q3 2024 | 11.84% |
| Q2 2024 | 18.88% |
| Q1 2024 | -49.55% |
| Q4 2023 | -50.81% |
| Q3 2023 | 194.45% |
| Q2 2023 | 60.85% |
| Q1 2023 | -23.95% |
| Q4 2022 | -15.52% |
| Q3 2022 | -17.29% |
| Q2 2022 | -28.43% |
| Q1 2022 | 96.75% |
| Q4 2021 | -19.43% |
| Q3 2021 | -4.26% |
| Q2 2021 | 34.90% |
| Q1 2021 | -13.37% |
| Q4 2020 | 45.41% |
| Q3 2020 | -3.74% |
| Q2 2020 | -30.47% |
| Q1 2020 | 20.32% |
| Q4 2019 | 7.07% |
| Q3 2019 | 3.00% |
| Q2 2019 | 49.44% |
| Q1 2019 | 102.91% |
| Q4 2018 | -1289.44% |
| Q3 2018 | 8.28% |
| Q2 2018 | 26.89% |
| Q1 2018 | 42.06% |
| Q4 2017 | 14.27% |
| Q3 2017 | -20.07% |
| Q2 2017 | 19.67% |
| Q1 2017 | 280.93% |
| Q4 2016 | 74.63% |
| Q3 2016 | -51.00% |
| Q2 2016 | 188.79% |
| Q1 2016 | 95.27% |
| Q4 2015 | 1252.00% |